Skip to main content
Gut logoLink to Gut
. 1976 Nov;17(11):906–910. doi: 10.1136/gut.17.11.906

Histocompatibility antigens in inflammatory bowel disease. Their clinical significance and their association with arthropathy with special reference to HLA-B27 (W27).

E G Mallas, P Mackintosh, P Asquith, W T Cooke
PMCID: PMC1411211  PMID: 1001980

Abstract

Histocompatibility (HLA) antigen phenotypes have been studied in 100 patients with ulcerative colitis, 100 with Crohn's disease, and 283 normal controls. In addition the incidence of ankylosing spondylitis, sacroiliitis, and "enteropathic" peripheral arthropathy was determined in the patients with inflammatory bowel disease (IBD). There was no significant difference in antigen frequency between patients and controls. However, the incidence of HLA-B27 was increased in the patients complicated by ankylosing spondylitis and/or sacroiliitis in both ulcerative colitis and Crohn's disease. In contrast, none of the 29 IBD patients with "enteropathic" peripheral arthropathy had B27 antigen. Furthermore, ankylosing spondylitis was found more frequently in ulcerative colitis bearing HLA-B27 compared with non-B27 patients (P less than 0-01). The same was found in Crohn's disease, although this difference was not statistically significant. In addition, 12 of 14 ulcerative colitis patients and five out of six Crohn's patients with HLA-B27 had total colitis, compared with the frequency of total colitis in non-B27 patients (P less than 0-024 and less than 0-03 respectively). The data suggest that B27 histocompatibility antigen could be a pathogenetic discriminator between the arthropathies in IBD and may be of prognostic significance with respect to extension and severity of the disease.

Full text

PDF
906

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ACHESON E. D. An association between ulcerative colitis, regional enteritis, and ankylosing spondylitis. Q J Med. 1960 Oct;29:489–499. [PubMed] [Google Scholar]
  2. ANSELL B. M., WIGLEY R. A. ARTHRITIC MANIFESTATIONS IN REGIONAL ENTERITIS. Ann Rheum Dis. 1964 Jan;23:64–72. doi: 10.1136/ard.23.1.64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Aho K., Ahvonen P., Lassus A., Sievers K., Tilikainen A. HL-A antigen 27 and reactive arthritis. Lancet. 1973 Jul 21;2(7821):157–157. doi: 10.1016/s0140-6736(73)93109-7. [DOI] [PubMed] [Google Scholar]
  4. Asquith P., Mackintosh P., Stokes P. L., Holmes G. K., Cooke W. T. Histocompatibility antigens in patients with inflammatory-bowel disease. Lancet. 1974 Jan 26;1(7848):113–115. doi: 10.1016/s0140-6736(74)92342-3. [DOI] [PubMed] [Google Scholar]
  5. Brewerton D. A., Caffrey M., Nicholls A., Walters D., James D. C. HL-A 27 and arthropathies associated with ulcerative colitis and psoriasis. Lancet. 1974 May 18;1(7864):956–958. doi: 10.1016/s0140-6736(74)91262-8. [DOI] [PubMed] [Google Scholar]
  6. Brewerton D. A., Caffrey M., Nicholls A., Walters D., Oates J. K., James D. C. Reiter's disease and HL-A 27. Lancet. 1973 Nov 3;302(7836):996–998. doi: 10.1016/s0140-6736(73)91091-x. [DOI] [PubMed] [Google Scholar]
  7. Brewerton D. A., Hart F. D., Nicholls A., Caffrey M., James D. C., Sturrock R. D. Ankylosing spondylitis and HL-A 27. Lancet. 1973 Apr 28;1(7809):904–907. doi: 10.1016/s0140-6736(73)91360-3. [DOI] [PubMed] [Google Scholar]
  8. Dausset J., Degos L., Hors J. The association of the HL-A antigens with diseases. Clin Immunol Immunopathol. 1974 Sep;3(1):127–149. doi: 10.1016/0090-1229(74)90029-4. [DOI] [PubMed] [Google Scholar]
  9. De Deuxchaisnes C. N., Huaux J. P., Fiasse R., De Bruyére M. Letter: Ankylosing spondylitis, sacroiliitis, regional enteritis, and HL-A 27. Lancet. 1974 Jun 15;1(7868):1238–1239. doi: 10.1016/s0140-6736(74)91064-2. [DOI] [PubMed] [Google Scholar]
  10. Gleeson M. H., Walker J. S., Wentzel J., Chapman J. A., Harris R. Human leucocyte antigens in Crohn's disease and ulcerative colitis. Gut. 1972 Jun;13(6):438–440. doi: 10.1136/gut.13.6.438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Grumet F. C., Coukell A., Bodmer J. G., Bodmer W. F., McDevitt H. O. Histocompatibility (HL-A) antigens associated with systemic lupus erythematosus. A possible genetic predisposition to disease. N Engl J Med. 1971 Jul 22;285(4):193–196. doi: 10.1056/NEJM197107222850403. [DOI] [PubMed] [Google Scholar]
  12. Jacoby R. K., Jayson M. I. HL-A 27 in Crohn's disease. Ann Rheum Dis. 1974 Sep;33(5):422–424. doi: 10.1136/ard.33.5.422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. KELLGREN J. H. Diagnostic criteria for population studies. Bull Rheum Dis. 1962 Nov;13:291–292. [PubMed] [Google Scholar]
  14. Kraft S. C., Kirsner J. B. Immunological apparatus of the gut and inflammatory bowel disease. Gastroenterology. 1971 May;60(5):922–951. [PubMed] [Google Scholar]
  15. Lewkonia R. M., Woodrow J. C., McConnell R. B., Evans D. A. Letter: HL-A antigens in inflammatory bowel disease. Lancet. 1974 Mar 30;1(7857):574–575. doi: 10.1016/s0140-6736(74)92771-8. [DOI] [PubMed] [Google Scholar]
  16. Morris R. I., Metzger A. L., Bluestone R., Terasaki P. I. HL-A-W27--a useful discriminator in the arthropathies of inflammatory bowel disease. N Engl J Med. 1974 May 16;290(20):1117–1119. doi: 10.1056/NEJM197405162902004. [DOI] [PubMed] [Google Scholar]
  17. Palumbo P. J., Ward L. E., Sauer W. G., Scudamore H. H. Musculoskeletal manifestations of inflammatory bowel disease. Ulcerative and granulomatous colitis and ulcerative proctitis. Mayo Clin Proc. 1973 Jun;48(6):411–416. [PubMed] [Google Scholar]
  18. Russell A. S., Percy J. S., Schlaut J., Sartor V. E., Goodhart J. M., Sherbaniuk R. W., Kidd E. G. Transplantation antigens in Crohn's disease: Linkage of associated ankylosing spondylitis with HL-Aw27. Am J Dig Dis. 1975 Apr;20(4):359–361. doi: 10.1007/BF01237793. [DOI] [PubMed] [Google Scholar]
  19. SHERLOCK P., BELL B. M., STEINBERG H., ALMY T. P. FAMILIAL OCCURRENCE OF REGIONAL ENTERITIS AND ULCERATIVE COLITIS. Gastroenterology. 1963 Sep;45:413–420. [PubMed] [Google Scholar]
  20. Schachter H., Kirsner J. B. Definitions of inflammatory bowel disease of unknown etiology. Gastroenterology. 1975 Mar;68(3):591–600. [PubMed] [Google Scholar]
  21. Schlosstein L., Terasaki P. I., Bluestone R., Pearson C. M. High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med. 1973 Apr 5;288(14):704–706. doi: 10.1056/NEJM197304052881403. [DOI] [PubMed] [Google Scholar]
  22. Singer H. C., Anderson J. G., Frischer H., Kirsner J. B. Familial aspects of inflammatory bowel disease. Gastroenterology. 1971 Oct;61(4):423–430. [PubMed] [Google Scholar]
  23. Svejgaard A., Platz P., Ryder L. P., Nielsen L. S., Thomsen M. HL-A and disease associations--a survey. Transplant Rev. 1975;22:3–43. doi: 10.1111/j.1600-065x.1975.tb01550.x. [DOI] [PubMed] [Google Scholar]
  24. Svejgaard A., Svejgaard E., Nielsen L. S., Jacobsen B. Some speculations on the associations between HL-A and disease based on studies of psoriasis patients and their families. Transplant Proc. 1973 Dec;5(4):1797–1798. [PubMed] [Google Scholar]
  25. TERASAKI P. I., MCCLELLAND J. D. MICRODROPLET ASSAY OF HUMAN SERUM CYTOTOXINS. Nature. 1964 Dec 5;204:998–1000. doi: 10.1038/204998b0. [DOI] [PubMed] [Google Scholar]
  26. Woodrow J. C. HL-A 27 and Reiter's syndrome. Lancet. 1973 Sep 22;2(7830):671–672. doi: 10.1016/s0140-6736(73)92505-1. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES